These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


71 related items for PubMed ID: 8545121

  • 1. Regulation of urokinase-type plasminogen activator expression by the v-mos oncogene.
    Lengye E, Singh B, Gum R, Nerlov C, Sabichi A, Birrer M, Boyd D.
    Oncogene; 1995 Dec 21; 11(12):2639-48. PubMed ID: 8545121
    [Abstract] [Full Text] [Related]

  • 2. Regulation of urokinase-type plasminogen activator expression by an ERK1-dependent signaling pathway in a squamous cell carcinoma cell line.
    Lengyel E, Gum R, Stepp E, Juarez J, Wang H, Boyd D.
    J Cell Biochem; 1996 Jun 01; 61(3):430-43. PubMed ID: 8761947
    [Abstract] [Full Text] [Related]

  • 3. Urokinase-type plasminogen activator gene regulation by polyomavirus middle-T antigen.
    Besser D, Urich M, Sakaue M, Messerschmitt A, Ballmer-Hofer K, Nagamine Y.
    Oncogene; 1995 Dec 07; 11(11):2383-91. PubMed ID: 8570190
    [Abstract] [Full Text] [Related]

  • 4. Regulation of the uPA gene in various grades of human glioma cells.
    Lakka SS, Bhattacharya A, Mohanam S, Boyd D, Rao JS.
    Int J Oncol; 2001 Jan 07; 18(1):71-9. PubMed ID: 11115541
    [Abstract] [Full Text] [Related]

  • 5. Elucidation of a signaling pathway induced by FGF-2 leading to uPA gene expression in NIH 3T3 fibroblasts.
    Besser D, Presta M, Nagamine Y.
    Cell Growth Differ; 1995 Aug 07; 6(8):1009-17. PubMed ID: 8547215
    [Abstract] [Full Text] [Related]

  • 6. Regulation of the urokinase-type plasminogen activator receptor gene in different grades of human glioma cell lines.
    Bhattacharya A, Lakka SS, Mohanam S, Boyd D, Rao JS.
    Clin Cancer Res; 2001 Feb 07; 7(2):267-76. PubMed ID: 11234878
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Mitogen-activated protein kinases Erk1/2 and p38 are required for maximal regulation of TIMP-1 by oncostatin M in murine fibroblasts.
    Tong L, Smyth D, Kerr C, Catterall J, Richards CD.
    Cell Signal; 2004 Oct 07; 16(10):1123-32. PubMed ID: 15240007
    [Abstract] [Full Text] [Related]

  • 11. Up-regulation of urokinase-type plasminogen activator expression by the HER2/neu proto-oncogene.
    Gum R, Wang SW, Lengyel E, Yu D, Hung MC, Juarez J, Boyd D.
    Anticancer Res; 1995 Oct 07; 15(4):1167-72. PubMed ID: 7653995
    [Abstract] [Full Text] [Related]

  • 12. MEKK1 regulates the AP-1 dimer repertoire via control of JunB transcription and Fra-2 protein stability.
    Cuevas BD, Uhlik MT, Garrington TP, Johnson GL.
    Oncogene; 2005 Jan 27; 24(5):801-9. PubMed ID: 15558021
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Requirement of TGF-beta receptor-dependent activation of c-Jun N-terminal kinases (JNKs)/stress-activated protein kinases (Sapks) for TGF-beta up-regulation of the urokinase-type plasminogen activator receptor.
    Yue J, Sun B, Liu G, Mulder KM.
    J Cell Physiol; 2004 May 27; 199(2):284-92. PubMed ID: 15040011
    [Abstract] [Full Text] [Related]

  • 15. EGF stimulates uPAR expression and cell invasiveness through ERK, AP-1, and NF-kappaB signaling in human gastric carcinoma cells.
    Baek MK, Kim MH, Jang HJ, Park JS, Chung IJ, Shin BA, Ahn BW, Jung YD.
    Oncol Rep; 2008 Dec 27; 20(6):1569-75. PubMed ID: 19020743
    [Abstract] [Full Text] [Related]

  • 16. Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system.
    Lee DH, Yang Y, Lee SJ, Kim KY, Koo TH, Shin SM, Song KS, Lee YH, Kim YJ, Lee JJ, Choi I, Lee JH.
    Cancer Res; 2003 Aug 01; 63(15):4648-55. PubMed ID: 12907645
    [Abstract] [Full Text] [Related]

  • 17. Activation mechanisms of the urokinase-type plasminogen activator promoter by hepatocyte growth factor/scatter factor.
    Ried S, Jäger C, Jeffers M, Vande Woude GF, Graeff H, Schmitt M, Lengyel E.
    J Biol Chem; 1999 Jun 04; 274(23):16377-86. PubMed ID: 10347197
    [Abstract] [Full Text] [Related]

  • 18. Evidence for an important role of serine 16 and its phosphorylation in the stabilization of c-Mos.
    Pham CD, Vuyyuru VB, Yang Y, Bai W, Singh B.
    Oncogene; 1999 Jul 29; 18(30):4287-94. PubMed ID: 10439036
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.